EVEROLIMUS IN COMBINATION WITH REDUCED TACROLIMUS IMPROVES KIDNEY FUNCTION VS STANDARD TACROLIMUS IN DE NOVO LIVER TRANSPLANT RECIPIENTS: HEPHAISTOS STUDY 12 MONTHS DATA

被引：0
|
作者：
Braun, F. [1 ,3 ]
Nashan, B. [1 ,3 ]
Pascher, A. [1 ,3 ]
Klein, C. G. [1 ,3 ]
Schemmer, P. [1 ,3 ]
Neumann, U. [1 ,3 ]
Kroeger, I. [2 ,4 ]
Wimmer, P. [2 ,4 ]
Schlitt, H. J. [1 ,3 ]
机构：
[1] Hephaistos Study Grp, Nurnberg, Germany
[2] Novartis Pharma GmbH, Nurnberg, Germany
[3] Hephaistos Study Grp, Nurnberg, Germany
[4] Novartis Pharma GmbH, Nurnberg, Germany
来源：
TRANSPLANT INTERNATIONAL | 2019年 / 32卷
关键词：
D O I：
暂无
中图分类号：
R61 [外科手术学];
学科分类号：
摘要：
V077
引用
收藏
页码：24 / 24
页数：1
相关论文
共 50 条
  • [31] Everolimus in De Novo Liver Transplant Recipients To Either Minimize or Eliminate Tacrolimus - Study Design and Update
    Filipponi, F.
    De Carlis, L.
    Metselaar, H. J.
    Nevens, F.
    Saliba, F.
    Junge, G.
    LIVER TRANSPLANTATION, 2010, 16 (06) : S132 - S133
  • [32] Effect of Everolimus With Low Dose Tacrolimus Vs Mycophenolate With Standard Tacrolimus Regimen in African-American De Novo Renal Transplant Recipients.
    Peddi, V.
    Qazi, Y.
    Shaffer, D.
    Luan, F.
    Shihab, F.
    Tomlanovich, S.
    McCague, K.
    Patel, D.
    Mulgaonkar, S.
    TRANSPLANTATION, 2014, 98 : 536 - 536
  • [33] EVEROLIMUS WITH REDUCED TACROLIMUS VERSUS STANDARD TACROLIMUS IN LIVING-DONOR LIVER TRANSPLANT RECIPIENTS: BASELINE DATA FROM THE H2307 STUDY
    Lopez, Patricia
    Levy, Gary
    Jeng, Long-Bin
    Suh, Kyung Suk
    Joo, Dong Jin
    Lee, Sung Gyu
    Lee, Wei-Chen
    Chen, Chao-Long
    Soin, Arvinder Singh
    Joh, Jae Won
    Yoshizumi, Tomoharu
    Grant, David
    Martzloff, El-Djouher
    Sips, Carole
    Wang, Zailong
    TRANSPLANT INTERNATIONAL, 2015, 28 : 459 - 459
  • [34] EVEROLIMUS WITH REDUCED TACROLIMUS VERSUS STANDARD TACROLIMUS IN LIVING-DONOR LIVER TRANSPLANT RECIPIENTS: BASELINE DATA FROM THE H2307 STUDY
    Settmacher, U.
    Braun, F.
    Sips, C.
    Dong, G.
    Kroeger, I.
    Sanchez, J. Aguilar
    TRANSPLANT INTERNATIONAL, 2015, 28 : 32 - 32
  • [35] Long term results of de novo kidney transplant recipients treated with the combination of low dose Tacrolimus and Everolimus.
    Silvestri, Patrizia
    Paola Salerno, Maria
    Zanoni, Natalia
    Spagnoletti, Gionata
    Citterio, Franco
    TRANSPLANTATION, 2024, 108 (9S)
  • [36] Long term results of de novo kidney transplant recipients treated with the combination of low dose Tacrolimus and Everolimus.
    Silvestri, Patrizia
    Salerno, Maria Paola
    Zanoni, Natalia
    Spagnoletti, Gionata
    Citterio, Franco
    TRANSPLANTATION, 2024, 108 (09) : 252 - 252
  • [37] RANDOMIZED, MULTICENTER STUDY OF EVEROLIMUS WITH EARLY REDUCTION OR ELIMINATION OF TACROLIMUS IN 719 DE NOVO LIVER TRANSPLANT RECIPIENTS: RESULTS AT 24 MONTHS
    Duvoux, C.
    Saliba, F.
    Durand, F.
    Neau-Cransac, N.
    Hardwigsen, J.
    Pageaux, G.
    Boleslawski, E.
    TRANSPLANT INTERNATIONAL, 2013, 26 : 2 - 2
  • [38] EVEROLIMUS ALLOWS A SIGNIFICANT AND SAFE REDUCTION OF TACROLIMUS EXPOSURE IN THE DE NOVO LIVER TRANSPLANTATION RECIPIENTS AND IMPROVES KIDNEY FUNCTION: 52 WEEKS DATA FROM REDUCE STUDY
    Navasa, Miquel
    Angel Gomez-Bravo, Miguel
    Prieto, Martin
    Sanchez-Antolin, Gloria
    Llado, Laura
    Otero, Alejandra
    Serrano, Trinidad
    Jimenez, Carlos
    Garcia, Miguel
    Santoyo, Julio
    TRANSPLANT INTERNATIONAL, 2017, 30 : 160 - 160
  • [39] Efficacy and Safety of Everolimus With Reduced Tacrolimus Compared to Standard Tacrolimus in Recipients of Living Donor Liver Transplant: Design of a Randomized Study.
    Grant, D.
    Levy, G.
    Song, G.
    Chen, C.
    Lee, W.
    Joh, J.
    Speziale, A.
    Rauer, B.
    Wang, Z.
    Junge, G.
    Uemoto, S.
    Suh, K.
    TRANSPLANTATION, 2014, 98 : 781 - 782
  • [40] Everolimus allows a significant and safe reduction of tacrolimus exposure in the de novo liver transplantation recipients and improves kidney function: 52 weeks data from REDUCE study
    Sanchez-Antolin, Gloria
    Gomez-Bravo, Miguel Angel
    Prieto, Martin
    Llado, Laura
    Otero, Alejandra
    Serrano, Maria Trinidad
    Jimenez, Carlos
    Garcia, Miguel
    Santoyo, Julio
    Navasa, Miquel
    HEPATOLOGY, 2017, 66 (06) : 1259A - 1260A
12345